What is preventing the use of high path avian flu vaccines?

High path avian influenza has affected close to 170 million birds over the past three years.

USDA is working to combat the virus and lower egg prices through a new strategy, which includes funding for vaccine research.

American Farm Bureau Economist Bernt Nelson spoke with RFD-TV’s Suzanne Alexander about current HPAI vaccines and what is preventing the use of them.

Related Stories
Pennsylvania Secretary of Agriculture Russell Redding discusses the recent surge in bird flu cases, the state’s expanded biosecurity response and efforts to support poultry producers.
USDA Farmer Bridge Assistance payments could begin this weekend as producers face tight margins, shifting acreage expectations, cattle herd contraction, and growing pressure for a stronger farm safety net.
Higher livestock prices reflect resilient demand, even as disease and herd shifts reshape 2026 supply expectations.
Rising beef supplies and lower cattle prices, weaker hog markets, and softening dairy prices will shape producer margins heading into 2026.
Georgia has regained its HPAI-free status after a swift response to October’s detection. Commissioner Tyler Harper urges producers to stay vigilant and maintain biosecurity.
A smaller U.S. turkey flock and resurgent avian flu have tightened supplies, driving prices higher even as other key holiday foods show mixed trends.